#adherenceinformed - Twitter Hashtag

Ankeet S. Bhatt, MD, MBA, ScM @ankeetbhatt

over 4 years ago

Timely work by #JohnOstrominski @mvaduganathan! Clear imperative for cost/value discussion in CV care. Even more relevant to new #adherenceinformed therapies (⬇️dosing freq,⬆️duration of action) & devices where RCT adherence ≈ 'real world' adherence. Thanks for including me!

ankeetbhatt's tweet photo. Timely work by #JohnOstrominski @mvaduganathan! Clear imperative for cost/value discussion in CV care. Even more relevant to new #adherenceinformed therapies (⬇️dosing freq,⬆️duration of action) & devices where RCT adherence ≈ 'real world' adherence. Thanks for including me! https://t.co/Ue9Ik5xCo3

Sameer Hirji @Hirji1987

over 4 years ago

Great collaboration and timely study to inform future guideline documents. @mvaduganathan #JohnOstrominski @ankeetbhatt @JavedButler1 @JJheart_doc @coconnormd @mfiuzat @gcfmd

2

27

3

1

0

17

3

0

Ankeet S. Bhatt, MD, MBA, ScM @ankeetbhatt

over 4 years ago

👇🏽current model curtails the potential benefits of discovery science by design. New therapies that are #adherenceinformed sorely needed for multiple CV conditions (ASCVD/HF/DM)

Sek Kathiresan MD

@skathire

over 4 years ago

Chronic care model (daily pills, intermittent injections) for LDL/ASCVD care = broken

0

23

1

0

3

0

Ankeet S. Bhatt, MD, MBA, ScM @ankeetbhatt

over 4 years ago

#polypills would certainly be an important leap forward; Therapies that are '#adherenceinformed' - meaning they compete on (1) ease of use/tolerance, (2) reducing polypharmacy, and/or (3) prolonged duration of action seem like the next frontier in HF - already happening for CVD

ankeetbhatt's tweet photo. #polypills would certainly be an important leap forward; Therapies that are '#adherenceinformed' - meaning they compete on (1) ease of use/tolerance, (2) reducing polypharmacy, and/or (3) prolonged duration of action seem like the next frontier in HF - already happening for CVD https://t.co/TbGohOfuhj

Swapnil Hiremath @hswapnil.medsky.social @hswapnil

over 4 years ago

@gcfmd @RangaswJ @mvaduganathan @JohnRMontford @KidneyInCVD @ankeetbhatt @SJGreene_md Agree with that We need a ‘heart failure’ polypill #AHA21

0

9

2

0

17

2

1

0

Ankeet S. Bhatt, MD, MBA, ScM @ankeetbhatt

almost 5 years ago

I argue for: 🎯 Better #metrics to capture true adherence 🎯 #Implementation RCTs with adherence-focused endpoints 🎯 '#Adherenceinformed' therapeutics facilitating durable adhere to the growing # of #evidencebased CV therapies @DLBHATTMD @yaleHFdoc @BrighamResearch

1

6

1

0